Načítá se...
Infectious complications of rituximab therapy in renal disease
Rituximab, an anti-CD20 monoclonal antibody, was originally used to treat B-cell malignancies. Its use has significantly increased in recent years, as it is now also used to treat a variety of autoimmune diseases including rheumatoid arthritis and ANCA-associated vasculitis (AAV). Initial studies su...
Uloženo v:
| Vydáno v: | Clin Kidney J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570071/ https://ncbi.nlm.nih.gov/pubmed/28852481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx038 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|